Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/22/2012WO2012158701A1 Protein matrix vaccine compositions including polycations
11/22/2012WO2012158657A1 Therapeutic anti-igf1r combinations
11/22/2012WO2012158643A1 Hendra and nipah virus g glycoprotein immunogenic compositions
11/22/2012WO2012158556A1 Tolerogenic plasmacytoid dendritic cells co-expressing cd8-alpha and cd8-beta and methods of inducing the differentiation of regulatory t cells using same
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012158123A1 Compounds and methods for treating insulin resistance syndrome
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157736A1 Immunity induction agent
11/22/2012WO2012157647A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
11/22/2012WO2012157589A1 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for testing cancer
11/22/2012WO2012157408A1 Cytotoxic t cell inducer
11/22/2012WO2012157237A1 Osteogenesis promoter
11/22/2012WO2012156975A1 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
11/22/2012WO2012156969A1 Allogeneic tumor cell vaccination
11/22/2012WO2012156750A1 Hiv vaccine
11/22/2012WO2012156666A1 Prion protein antibodies for the treatment of alzheimer's disease
11/22/2012WO2012156532A1 Anti-human-her3 antibodies and uses thereof
11/22/2012WO2012156522A1 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
11/22/2012WO2012156505A1 Antibodies against tropomyosin-related kinase b receptors
11/22/2012WO2012156452A1 Method for detecting infections
11/22/2012WO2012156437A1 Method for egfr directed combination treatment of cancer
11/22/2012WO2012156430A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
11/22/2012WO2012156391A1 Vaccine against streptococcus pneumoniae
11/22/2012WO2012156351A1 Epha4 is a disease modifier in motor neuron disease
11/22/2012WO2012156309A1 Antibodies against her3
11/22/2012WO2012156219A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
11/22/2012WO2012156018A1 Antibodies for treatment of cancer expressing claudin 6
11/22/2012WO2012155819A1 Hbv specific antibody
11/22/2012WO2012155751A1 A method for preparing hbv vaccine comprising aluminum adjuvant
11/22/2012WO2012155262A1 Virus-like particles and process for preparing same
11/22/2012WO2012155261A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
11/22/2012WO2012131004A3 Antibodies directed against icos and uses thereof
11/22/2012WO2012129873A3 Method for preparing antitumor biological product
11/22/2012WO2012122533A3 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
11/22/2012WO2012118559A3 Tetravalent and mixed head bivalent dengue vaccine
11/22/2012WO2012115474A3 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
11/22/2012WO2012112443A3 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
11/22/2012WO2012082752A3 Anti-ccl25 and anti-ccr9 antibodies for the prevention and treatment of cancer and cancer cell migration
11/22/2012WO2012045067A3 Mammalian genes involved in infection
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120295802 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
11/22/2012US20120295350 Prospective Identification and Characterization of Breast Cancer Stem Cells
11/22/2012US20120294951 Use of goat serum for veterinary treatment
11/22/2012US20120294948 Vaccine
11/22/2012US20120294899 Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
11/22/2012US20120294897 Bioactive fraction of petiveria alliacea, pharmaceutical composition containing same, and combination with immunostimulants for treating cancer
11/22/2012US20120294894 Pharmaceutical composition and method for producing the same
11/22/2012US20120294893 Edible jelly-form composition, jelly-form preparation and method for producing jelly-form preparation
11/22/2012US20120294892 Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same
11/22/2012US20120294891 Materials and methods for detecting, preventing, and treating retroviral infection
11/22/2012US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines
11/22/2012US20120294889 Chimeric Flavivirus Vaccines
11/22/2012US20120294888 Tolerogenic synthetic nanocarriers for allergy therapy
11/22/2012US20120294886 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
11/22/2012US20120294885 Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
11/22/2012US20120294884 Methods of blocking tissue destruction by autoreactive t cells
11/22/2012US20120294883 Oligomeric receptor ligand pair member complexes
11/22/2012US20120294881 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
11/22/2012US20120294880 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/22/2012US20120294879 Consensus sequence for influenza a virus
11/22/2012US20120294878 Tlr-2 agonists and methods of use thereof
11/22/2012US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/22/2012US20120294876 Vaccine and health-related applications for ruminant breath monitoring system
11/22/2012US20120294875 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth
11/22/2012US20120294874 Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof
11/22/2012US20120294873 ANTI-EpCAM IMMUNOGLOBULINS
11/22/2012US20120294872 Method of Predicting and Reducing Risk of Metastasis of Breast Cancer to Lung
11/22/2012US20120294871 Modulation of gpcr-mediated camp production through lrp6 and its therapeutic application
11/22/2012US20120294870 Compositions and methods for diagnosis and treatment of tumors
11/22/2012US20120294869 Methods for Treating Fatty Liver Disease
11/22/2012US20120294868 Anti-tgf-beta induction of bone cell function and bone growth
11/22/2012US20120294867 Method for egfr directed combination treatment of cancer
11/22/2012US20120294866 Pharmaceutical formulation for proteins
11/22/2012US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation
11/22/2012US20120294864 Endoglin Antibodies
11/22/2012US20120294863 Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
11/22/2012US20120294862 Antagonists of il-17a, il-17f, and il-23p19
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012US20120294860 Medicament for treating and/or preventing cancer
11/22/2012US20120294859 Cancer stem cell markers and uses thereof
11/22/2012US20120294858 Use of long-acting recombinant human soluble tumor necrosis factor alpha receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure
11/22/2012US20120294857 Monomeric Bi-Specific Fusion Protein
11/22/2012US20120294856 Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer
11/22/2012US20120294855 Glp-1 receptor agonist compounds for obstructive sleep apnea
11/22/2012US20120294854 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
11/22/2012US20120294853 CD19 Binding Agents and Uses Thereof
11/22/2012US20120294852 Antagonists of il-6 to raise albumin and/or lower crp
11/22/2012US20120294851 Cancer Therapies and Pharmaceutical Compositions Used Therein
11/22/2012US20120294850 Ganglioside Epitopes For Treating Guillain-Barre Syndrome
11/22/2012US20120294849 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
11/22/2012US20120294848 IGE CH3 Peptide Vaccine
11/22/2012US20120294847 Immunoglobulin reduced in thrombogenic agents and preparation thereof
11/22/2012US20120294846 Treatment of Pulmonary and Pleural Fibrosis Using HSP27 Inhibitors
11/22/2012US20120294845 Method of making a polymer preferably an (alkyl) acryloyl polycarbonate, the polymer and (alkyl) acryloyl polycarbonate obtained, and a biodevice comprising same
11/22/2012US20120294831 Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
11/22/2012US20120294830 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
11/22/2012US20120294822 Use of anti-cgrp antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated cgrp levels
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294800 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
11/22/2012US20120294799 Anti-tem1 antibodies and uses thereof
1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 1823